In his last interview at age 87 in 2009, Leon Eisenberg, an American child psychiatrist, social psychiatrist and medical educator, also known as the ‘father’ of ADHD, said “ADHD is a prime example of a fictitious disease.”
Although some believe that Dr. Eisenberg’s statement was an “exaggeration,” a number of medical experts hold that Attention Deficit Hyperactivity Disorder is actually often “over diagnosed” as a result of vague diagnostic practices. This is clearly explained by Harvard psychologist Jerome Kagan, one of the most renowned experts in child development in the world at present:
“Let’s go back 50 years. We have a 7-year-old child who is bored in school and disrupts classes. Back then, he was called lazy. Today, he is said to suffer from ADHD (Attention Deficit Hyperactivity Disorder). . . . Every child who’s not doing well in school is sent to see a pediatrician, and the pediatrician says: “It’s ADHD; here’s Ritalin.” As a matter of fact, 90% of these 5.4 million children don’t have an abnormal dopamine metabolism. Sadly, doctors make a diagnosis if a drug is available to them.
According to Psychiatric News, this “fictitious disease” helped Eisenberg make quite a living thanks to pharmaceutical sales. He even received the “Ruane Prize for Child and Adolescent Psychiatry Research. He has been a leader in child psychiatry for more than 40 years through his work in pharmacological trials, research, teaching, and social policy and for his theories of autism and social medicine.”
Unfortunately, the medical industry made great use of his theories and instead of truly helping children in need, it actually worked toward depersonalizing and disconnecting children from a healthy, normal upbringing. Parents are usually left with no option but to put their children on these drugs.
Surprisingly, only in the US, 1 in 10 boys aged 10 is on ADHD medication on a regular daily basis. And this trend is constantly on the rise.
According to American psychologist Lisa Cosgrove and her fellow-colleagues in their study “Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry,” “of the 170 DSM panel members 95 (56 percent) had one or more financial associations with companies in the pharmaceutical industry. One hundred percent of the members of the panels on ‘Mood Disorders’ and ‘Schizophrenia and Other Psychotic Disorders’ had financial ties to drug companies.”
In reality, doctors are benefiting greatly from their collaboration with pharmaceutical companies. Just for an illustration, the assistant director of the Pediatric Psychopharmacology Unit at Massachusetts General Hospital and associate professor of Psychiatry at Harvard Medical School earned “$1 million in earnings from drug companies between 2000 and 2007.”
The results of a study conducted by Marc-André Gagnon and Joel Lexchin, researchers of pharmaceutical promotion, revealed that in 2004 the U.S. pharmaceutical industry spent 24.4% of the sales on promotion, as opposed to 13.4% on research and development. In other words, they spent twice as much money to administer their drugs to people than the amount they spent on testing the efficacy and safety of these drugs.
The question if these drugs are safe for use still remains.
These are the side effects cited on antidepressants’ labels:
– Manic reactions
– Suicidal ideation
– Loss of consciousness
– Feeling drunk
– Alcohol abuse
– Homicidal ideation
Why would any parent choose to subject their child to drugs with such highly dangerous side effects?
In the words of Dr. Edward C. Hamlyn, a founding member of the Royal College of General Practitioners, in 1998, “ADHD is fraud intended to justify starting children on a life of drug addiction.”